IGP — Imperial Ginseng Products Income Statement
0.000.00%
Last trade - 00:00
- CA$0.77m
- CA$0.40m
- CA$4.30m
- 27
- 17
- 60
- 27
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.81 | 5.79 | 7.2 | 3.44 | 4.3 |
Cost of Revenue | |||||
Gross Profit | 0.242 | 0.158 | 0.179 | -0.206 | 0.051 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 14.7 | 15.6 | 9.12 | 6.49 | 6.4 |
Operating Profit | -6.9 | -9.78 | -1.93 | -3.05 | -2.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.75 | -10 | -5.71 | 2.98 | 4.03 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.95 | -7.35 | -4.48 | 2.32 | 2.92 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.95 | -7.35 | -4.48 | 2.32 | 2.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.95 | -7.35 | -4.48 | 2.32 | 2.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.162 | -0.213 | -0.204 | 0.385 | 0.034 |
Special Dividends per Share |